Drug Maker Akorn Seeks Bankruptcy Reorganization, Cites Litigation ‘Overhangs’
WILMINGTON, Del. — Drug manufacturer Akorn Inc. on May 20 filed a voluntary petition for reorganization under federal bankruptcy laws, saying it has agreed to an “in-court sale” of its business...To view the full article, register now.
Already a subscriber? Click here to view full article